Open Access. Powered by Scholars. Published by Universities.®
- Discipline
- Keyword
-
- COPD (2)
- Antibiotic therapy (1)
- Beta-lactam (1)
- BiPAP (1)
- COVID clinical decision making (1)
-
- COVID-19 (1)
- Cancer (1)
- Community-acquired pneumonia (1)
- Direct-to-consumer advertising (1)
- Endotracheal intubation (1)
- Incentive spirometry (1)
- Indwelling pleural catheterization (1)
- Legionella pneumonia (1)
- Pleural effusion (1)
- Pleurodesis (1)
- Postoperative pulmonary complications (1)
- Pulmonary hypertension (1)
- Quality of life (1)
- Remdesivir (1)
- SGLT2 (1)
- Sleep apnea (1)
- Stem cell therapy (1)
Articles 1 - 9 of 9
Full-Text Articles in Respiratory Tract Diseases
Use Of Empagliflozin As An Adjuvant Treatment For Obstructive Sleep Apnea For A Patient Who Has Not Seen A Physician In Over 40 Years, Andrew Demko
Clinical Research in Practice: The Journal of Team Hippocrates
A clinical decision report using:
Neeland IJ, Eliasson B, Kasai T, et al. The Impact of Empagliflozin on Obstructive Sleep Apnea and Cardiovascular and Renal Outcomes: An Exploratory Analysis of the EMPA-REG OUTCOME Trial. Diabetes Care. 2020;43(12):3007-3015. https://doi.org/10.2337/dc20-1096
for a patient with obstructive sleep apnea who has not seen a physician in over 40 years.
Indwelling Pleural Catheterization Maximizes Functionality And Quality Of Life In Management Of Recurrent Malignant Pleural Effusions, Avinash Ramkissoon
Indwelling Pleural Catheterization Maximizes Functionality And Quality Of Life In Management Of Recurrent Malignant Pleural Effusions, Avinash Ramkissoon
Clinical Research in Practice: The Journal of Team Hippocrates
A clinical decision report using:
Davies HE, Mishra EK, Kahan BC, et al. Effect of an indwelling pleural catheter vs chest tube and talc pleurodesis for relieving dyspnea in patients with malignant pleural effusion: The TIME2 randomized controlled trial. J Am Med Assoc. 2012;307(22):2383-2389. https://doi.org/10.1001/jama.2012.5535
for the management of recurrent malignant pleural effusions in a patient with metastatic renal cell carcinoma.
The Decision I Never Thought I Would Have To Make, Mary Nixon
The Decision I Never Thought I Would Have To Make, Mary Nixon
Clinical Research in Practice: The Journal of Team Hippocrates
A brief essay on how the COVID pandemic has changed how we think about medicine and our patients.
Remdesivir Has Questionable Efficacy In Patients With Severe Covid-19 Receiving High-Flow Oxygen, Gabriel Burdick
Remdesivir Has Questionable Efficacy In Patients With Severe Covid-19 Receiving High-Flow Oxygen, Gabriel Burdick
Clinical Research in Practice: The Journal of Team Hippocrates
A clinical decision report using:
Beigel JH, Tomashek KM, Dodd LE, et al. Remdesivir for the Treatment of Covid-19 — Final Report. N Engl J Med. 2020;383:1813-1826. https://doi.org/10.1056/NEJMoa2007764
for a patient with severe COVID-19.
Weak Evidence, Supplemented With Common Sense For Reduction In Postoperative Pulmonary Complications, Natalie M. Wiseman
Weak Evidence, Supplemented With Common Sense For Reduction In Postoperative Pulmonary Complications, Natalie M. Wiseman
Clinical Research in Practice: The Journal of Team Hippocrates
A clinical decision report appraising:
Kaminski PN, Forgiarini LA, Jr., Andrade CF. Early respiratory therapy reduces postoperative atelectasis in children undergoing lung resection. Respir Care. 2013;58(5):805-809. https://doi.org/10.4187/respcare.01870
for prevention of postoperative pulmonary complications following thoracic surgery for a patient who is not able to participate in incentive spirometry.
Deciding When To Use Bipap For Patients With Acute Exacerbations Of Copd, Akhil Vedere
Deciding When To Use Bipap For Patients With Acute Exacerbations Of Copd, Akhil Vedere
Clinical Research in Practice: The Journal of Team Hippocrates
A clinical decision report appraising Carrera M, Marín JM, Antón A, et al. A controlled trial of noninvasive ventilation for chronic obstructive pulmonary disease exacerbations. J Crit Care. 2009;24(3). https://doi.org/10.1016/j.jcrc.2008.08.007
There Is No Mortality Benefit To Using Quinolones Instead Of Azithromycin For Legionella Pneumonia, David B. Witcher
There Is No Mortality Benefit To Using Quinolones Instead Of Azithromycin For Legionella Pneumonia, David B. Witcher
Clinical Research in Practice: The Journal of Team Hippocrates
A critical appraisal and clinical application of Gershengorn HB, Keene A, Dzierba AL, Wunsch H. The association of antibiotic treatment regimen and hospital mortality in patients hospitalized with Legionella pneumonia. Clinical Infectious Diseases. 2015;60(11):e66-e79. doi: 10.1093/cid/civ157
Stem Cell Therapy For End Stage Copd: A Cautionary Tale Of Direct-To-Consumer Advertising, Blake J. Arthurs, Scott Yaekle
Stem Cell Therapy For End Stage Copd: A Cautionary Tale Of Direct-To-Consumer Advertising, Blake J. Arthurs, Scott Yaekle
Clinical Research in Practice: The Journal of Team Hippocrates
A critical appraisal and clinical application of Weiss DJ, Casaburi R, Flannery R, LeRoux-Williams M, Tashkin DP. A placebo-controlled, randomized trial of mesenchymal stem cells in COPD. Chest. 2013;143(6):1590-1598. doi: 10.1378/chest.12-2094
New Evidence Prompts Rethinking The Clinical Management Of Community Acquired Pneumonia In Patients Admitted To General Medical Services., J. Timothy Caldwell
New Evidence Prompts Rethinking The Clinical Management Of Community Acquired Pneumonia In Patients Admitted To General Medical Services., J. Timothy Caldwell
Clinical Research in Practice: The Journal of Team Hippocrates
A critical appraisal and clinical application of Postma DF, van Werkhoven CH, van Elden LJR, et al. Antibiotic treatment strategies for community-acquired pneumonia in adults. N Engl J Med. 2015;372(14):1312-1323. doi:10.1056/NEJMoa1406330